Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Cogent Biosciences, Inc. logo

Cogent Biosciences, Inc. (COGT) Stock Ticker

NASDAQ: COGT · Healthcare · Biotechnology
$32.31+2.80%
USD · as of 2026-09-28 · market cap $5.5B
Open COGT in TickrDownload for iPhone

COGT right now

Options expect by Oct 6±8.6%
Options expect by Oct 29±17.8%
Priced in for Nov 6 earnings±20.0%
IV rank (30-day)9% · cheap
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full COGT picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on COGT
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Cogent Biosciences, Inc.

Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted treatments for illnesses rooted in specific genetic anomalies. The company's primary therapeutic candidate is CGT9486, a selective tyrosine kinase inhibitor engineered to block the KIT D816V mutation, a key driver of systemic mastocytosis, along with other KIT exon 17 mutations observed in individuals suffering from advanced gastrointestinal stromal tumors (GIST). Furthermore, Cogent holds a licensing pact with Plexxikon Inc., granting it rights for the investigation, advancement, and marketing of bezuclastinib. Previously known as Unum Therapeutics Inc., the company adopted its current name, Cogent Biosciences, Inc., in October 2020. Established in 2014, Cogent Biosciences is headquartered in Cambridge, Massachusetts.

COGT stock facts

Ticker symbolCOGT
ExchangeNASDAQ Global Select
SectorHealthcare
IndustryBiotechnology
Market cap$5.5B
CEOAndrew R. Robbins
Employees258
HeadquartersWaltham, MA, US
IPO date2018-03-29
Websitewww.cogentbio.com

What you can see for COGT on Tickr

Live COGT price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the COGT report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Cogent Biosciences, Inc.?

The ticker symbol for Cogent Biosciences, Inc. is COGT, listed on the NASDAQ Global Select.

What is COGT?

Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted treatments for illnesses rooted in specific genetic anomalies. The company's primary therapeutic candidate is CGT9486, a selective tyrosine kinase inhibitor engineered to block the KIT D816V mutation, a key driver of systemic mastocytosis, along with other KIT exon 17 mutations observed in individuals suffering from…

HomeExploreMarketLists
All pages